281740.KQ281740.KQKOE
Loading
EBITDA Over TimeContracting
Percentile Rank33
3Y CAGR-31.0%
5Y CAGR+7.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-31.0%/yr
Annual compound
5Y CAGR
+7.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$13.27B-65.0%
2024$37.89B-6.3%
2023$40.46B+0.0%
2022$40.45B+52.1%
2021$26.59B+189.1%
2020$9.20B+38.2%
2019$6.66B-